Worldwide Drug Delivery Market Analysis & Outlook, 2019 to 2024 - Rising R&D investments are Driving Growth
Ascendis Pharma A/S - American Depositary Shares (ASND)
Last ascendis pharma a/s - american depositary shares earnings: 11/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ascendispharma.com
Company Research
Source: GlobeNewswire
Dublin, March 21, 2019 (GLOBE NEWSWIRE) -- The "Drug Delivery Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering. The drug delivery market is projected to grow at a CAGR of 7.93% to reach US$1,058.792 billion by 2024, from US$669.691 billion in 2018.Drug delivery is referred to the transfer of drug into the human body either manually or through drug delivery systems or carriers via oral, nasal or skin. These are in high demand due to the growing prevalence of certain diseases which require targeted drug treatments like cancer.Rising R&D investments, growing healthcare expenditures and growing age-related diseases with the increasing elderly population worldwide are also driving the growth of the global drug delivery market in the forecast period. Drug delivery systems/devices/technologies control the rate of drug release and the drug is released to a specific diseased location.Major industry players profiled as part of
Show less
Read more
Impact Snapshot
Event Time:
ASND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASND alerts
High impacting Ascendis Pharma A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ASND
News
- United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic HypoparathyroidismGlobeNewswire
- Ascendis Pharma A/S (NASDAQ: ASND) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $116.00 price target on the stock.MarketBeat
- Ascendis Pharma A/S (NASDAQ: ASND) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $173.00 price target on the stock.MarketBeat
- Nacuity Pharmaceuticals Expands Board of Directors with Appointment of Dr. Emmett Cunningham, Jr. [Yahoo! Finance]Yahoo! Finance
- Nacuity Pharmaceuticals Expands Board of Directors with Appointment of Dr. Emmett Cunningham, Jr.GlobeNewswire
ASND
Earnings
- 2/7/24 - Beat
ASND
Sec Filings
- 4/24/24 - Form 6-K
- 4/10/24 - Form 6-K
- 3/27/24 - Form 6-K
- ASND's page on the SEC website